Therapeutic T cell engineering
Crossref DOI link: https://doi.org/10.1038/nature22395
Published Online: 2017-05-25
Published Print: 2017-05-25
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sadelain, Michel
Rivière, Isabelle
Riddell, Stanley
Text and Data Mining valid from 2017-05-25
Version of Record valid from 2017-05-25
Article History
Received: 3 March 2017
Accepted: 26 April 2017
First Online: 25 May 2017
Competing interests
: S.R., I.R. and M.S. are consultants for Juno Therapeutics.